C. Willame

First name

C.

Last name

Willame

Baril, L., Rosillon, D., Willame, C., Angelo, M. G., Zima, J., van den Bosch, J. H., et al. (2015). Risk of spontaneous abortion and other pregnancy outcomes in 15-25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom. Vaccine. http://doi.org/10.1016/j.vaccine.2015.07.024

View

Willame, C., Rosillon, D., Zima, J., Angelo, M. G., Stuurman, A. L., Vroling, H., et al. (2016). Risk of new onset autoimmune disease in 9- to 25-year-old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom. Hum Vaccin Immunother. http://doi.org/10.1080/21645515.2016.1199308

View

Willame, C., Baril, L., van den Bosch, J., Ferreira, G. L., Williams, R., Rosillon, D., & Cohet, C. (2016). Importance of feasibility assessments before implementing non-interventional pharmacoepidemiologic studies of vaccines: lessons learned and recommendations for future studies. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4081

View

Povey, M., Aris, E., Cheuvart, B., Hall, G., Cohet, C., & Willame, C. (2021). Effectiveness of "Priorix" Against Measles and Mumps Diseases in Children Born After 2004 in the United Kingdom: A Retrospective Case-control Study Using the Clinical Practice Research Datalink GOLD Database. Pediatr Infect Dis J. http://doi.org/10.1097/inf.0000000000003111

View